Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -30.43% | -75.38% | - | - | 400K | ||
| -1.29% | -1.76% | +51.98% | +64.66% | 66.33B | ||
| -0.09% | +2.79% | +10.75% | +95.02% | 60.62B | ||
| +0.63% | +1.64% | +24.25% | +89.70% | 55.5B | ||
| -1.03% | -1.15% | +9.54% | +118.08% | 47.58B | ||
| -0.01% | -5.01% | +22.56% | +29.34% | 43.69B | ||
| -3.11% | -16.22% | +142.52% | +689.08% | 37.27B | ||
| +0.23% | +1.66% | +14.85% | +49.06% | 36.57B | ||
| +2.35% | -3.61% | +78.64% | +60.70% | 32.22B | ||
| +1.63% | +6.34% | -37.46% | +405.16% | 26.58B | ||
| Average | -3.09% | +0.33% | +35.29% | +177.87% | 45B | |
| Weighted average by Cap. | -0.21% | +0.33% | +35.13% | +152.89% |
Employees
-
















